South Atlantic Industries exec jailed
This article was originally published in The Tan Sheet
Executive Summary
Former President Roger Perry sentenced to 30 months in prison, three years supervised release, 200 hours community service for conspiracy to defraud and mislead by introducing adulterated and misbranded drugs into interstate commerce, U.S. Attorney for South Carolina announces Jan. 17. SAI purported to make generic OTC cough/cold formulas and stomach remedies, but produced drugs without proper actives and submitted store-bought and repackaged products to potential customers. Perry pleaded guilty in September (1"The Tan Sheet" Oct. 1, 2001, In Brief)...
You may also be interested in...
South Atlantic Industries
Former exec pleads guilty in Greenville, S.C. federal court Sept. 24 to misbranding OTCs. Roger Perry was president of firm which purported to make generic cough syrup, cold formulas, liquid antacid and stomach remedies from March 1997 to March 1998, U.S. Attorney's Office in Greenville says. SAI produced drugs without proper actives and Perry "caused employees...to purchase similar generic products from drug stores or other retail outlets, repackage the products in South Atlantic Industries bottles and submit these as 'samples' of real products to potential customers and to independent laboratories for analysis," U.S. Attorney says. Perry faces up to five years in prison, $250,000 fine. FDA says SAI ceased operations following a 1998 injunction filed by the agency stemming from GMP problems
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.